The IDEAL team will test this new model on targets known to be relevant in ovarian cancer, the deadliest of gynecologic ...
The tech company’s prices appear set to undercut the long list of competing telehealth companies that rely on aggressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback